Your browser doesn't support javascript.
loading
Prevalence of depression, anxiety in China during the COVID-19 pandemic: an updated systematic review and meta-analysis.
Bin, Xiang; Qu, Ke-Yi; Wang, Yu-Hao; Chen, Li; Xiong, Yan-Jie; Wen, Jin Fu; Wei, Hua-Bo; Bing, Tan; Dan, Chun-Yan; Zhu, Jia-Quan.
Afiliación
  • Bin X; Department of Otolaryngology, Fengdu County People's Hospital, Chongqing, China.
  • Qu KY; Department of Stomatology, Fengdu County People's Hospital, Chongqing, China.
  • Wang YH; Shandong Academy of Medical Sciences, Shandong First Medical University, Shandong, China.
  • Chen L; Department of Pharmacy, Fengdu County People's Hospital, Chongqing, China.
  • Xiong YJ; Department of Pharmacy, Fengdu County People's Hospital, Chongqing, China.
  • Wen JF; Institute of Cardiovascular Endocrinology of Shandong First Medical University, Shandong Academy of Medical Sciences, Shandong, China.
  • Wei HB; Department of Pharmacy, Fengdu County People's Hospital, Chongqing, China.
  • Bing T; Department of Pharmacy, Fengdu County People's Hospital, Chongqing, China.
  • Dan CY; Department of Human Resources, Fengdu County People's Hospital, Chongqing, China.
  • Zhu JQ; Department of Pharmacy, Fengdu County People's Hospital, Chongqing, China.
Front Public Health ; 11: 1267764, 2023.
Article en En | MEDLINE | ID: mdl-38249392
ABSTRACT

Background:

Mental health risks associated with the aftermath of the COVID-19 pandemic are often overlooked by the public. The aim of this study was to investigate the effects of the COVID-19 pandemic on depression and anxiety disorders in China.

Methods:

Studies were analyzed and extracted in accordance with the PRISMA 2020 flowchart. The studies were screened and extracted using electronic databases including PubMed, Web of Science, Embase, Cochrane Library, and ClinicalTrials.gov according to the predefined eligibility criteria. The Cochrane Review Manager software 5.3.1 was used for data analysis and the risk of bias assessment.

Results:

As of 2023, a total of 9,212,751 Chinese have been diagnosed with COVID-19 infection. A total of 913,036 participants in 44 studies were selected following the eligibility criteria, the statistical information of which was collected for meta-analysis. The pooled prevalence of depression and anxiety were 0.31 (95% CI 0.28, 0.35; I2 = 100.0%, p < 0.001) and 0.29 (95% CI 0.23, 0.36; I2 = 100.0%, p < 0.001), respectively. After performing a subgroup analysis, the prevalence of depression among women, healthcare workers, students, and adolescents was 0.31 (95% CI 0.22, 0.41), 0.33 (95% CI 0.26, 0.44), 0.32 (95% CI 0.26, 0.39), and 0.37 (95% CI 0.31, 0.44), respectively.

Conclusion:

The prevalence of depression and anxiety among the Chinese was overall high. Monitoring and surveillance of the mental health status of the population during crises such as sudden global pandemics are imperative. Systematic review registration https//clinicaltrials.gov/, identifier [CRD42023402190].
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pandemias / COVID-19 Tipo de estudio: Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Aspecto: Patient_preference Límite: Adolescent / Female / Humans País/Región como asunto: Asia Idioma: En Revista: Front Public Health Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pandemias / COVID-19 Tipo de estudio: Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Aspecto: Patient_preference Límite: Adolescent / Female / Humans País/Región como asunto: Asia Idioma: En Revista: Front Public Health Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza